Medical response in a nuclear or radiological emergency

Medical management by a physician or nurse Medical management questionnaire (preparation of the medical record) Part 1: General medical management 11 • Pathology and treatment: Glasgow Coma Score – Dominant pathologies (Absolute Urgencies – AU / Relative Urgencies – RU): skull, thorax, abdomen, burned, poisoned, blast, fracture, polytraumatised, spine, other chemical, biological, radiological, nuclear (CBRN) risk? Diagnosis and treatment (peripheral venous catheter, intraosteal route, tourniquet, intubated). Development: improvement, stabilisation, aggravation (AU / RU / DECD)? 12 • Transport and destination: medicalised, non-medicalised, destination, service, means of transport, time, follower card (Victim Assembly Area – VAA / Advanced Medical Post – AMP / triage)? 13 • Medical surveillance and development: clinical, samples, therapeutic. Part 2: Radiological management (radiological evaluation sheet) Required information list: 14 • Acute radiation: yes/no, date and time, type of radiation (gamma/X-ray, neutrons), whole body and/or localised (part of body), estimated dose in gray (Gy) and diagram showing positioning with respect to the source. 15 • Headaches and/or impaired consciousness: yes/no, date and time. 16 • Early erythema: yes/no, location, date and time. 17 • Nausea and/or vomiting and/or diarrhoea: yes/no, date and time. 18 • Hyperthermia: yes/no, date and time. 19 • Guidance: total estimated dose (gamma/X-ray + neutrons) < 1 Gy (monitoring by) / total estimated dose (gamma/X-ray + neutrons) > 1 Gy Hospital 10 • Associated chemical risk: yes/no. Chemical agents concerned. 11 • External contamination: yes/no (if yes, indicate the contaminated zone). 12 • Emergency decontamination: yes/no, date and time. 13 • Full decontamination performed: yes/no, date and time. 14 • Residual external contamination: yes/no, detected or suspected radionuclides. Diagram of the residual contamination 15 • Internal contamination suspected: yes/no. 16 • Internal contamination: measured by in-vivo radiation measurement (yes/non), radionuclides and activities measured, suspected (yes/no), radionuclides. 17 • Contaminated wound: yes/no, location. 18 • Measurements – samples: in-vivo radiation measurement – urine radiotoxicology – nostril sampling – skin appendage sampling indicating location (or time-stamped) – time-stamped blood samples: Complete Blood Count (CBC), platelets, reticulocytes / haemostasis biochemistry enzymology / sodium-24 / phenotyping of the erythrocytes (red blood cells) / HLA class I and II typing / chromosomal aberrations. 19 • Internal contamination treatment: Potassium iodide (yes/no, time). This treatment is administered as quickly as possible in cases of internal contamination by radioactive iodine – Radiogardase® (yes/no, time, dosage) – Ca‑DTPA administered by slow IV injection or perfusion (yes/no, time, dosage) – Ca‑DTPA by inhalation (yes/no, time) – DTPA on contaminated wound: one or more vials (yes/no, time). 08 MEDICAL RESPONSE STRATEGY Questioning and description of the circumstances of an event SHEET 05 Download the medical management questionnaire Word file MEDICAL RESPONSE IN NUCLEAR OR RADIOLOGICAL EMERGENCY 23

RkJQdWJsaXNoZXIy NjQ0NzU=